| Breakdown | TTM | Feb 2025 | Feb 2024 | Aug 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.09B | 13.20B | 25.29B | 25.39B | 24.65B | 23.55B |
| Gross Profit | 6.67B | 7.84B | 15.01B | 14.94B | 14.21B | 13.34B |
| EBITDA | 17.06B | 8.28B | 15.96B | 15.99B | 15.50B | 14.73B |
| Net Income | 12.20B | 5.85B | 11.34B | 11.32B | 10.57B | 9.84B |
Balance Sheet | ||||||
| Total Assets | 330.62B | 328.69B | 325.69B | 327.05B | 328.47B | 327.82B |
| Cash, Cash Equivalents and Short-Term Investments | 12.14B | 9.91B | 11.49B | 14.86B | 13.05B | 12.26B |
| Total Debt | 169.70B | 168.50B | 166.00B | 167.50B | 169.50B | 169.50B |
| Total Liabilities | 177.75B | 176.32B | 173.61B | 175.18B | 177.30B | 176.90B |
| Stockholders Equity | 152.87B | 152.37B | 152.08B | 151.87B | 151.17B | 150.93B |
Cash Flow | ||||||
| Free Cash Flow | 7.60B | 7.36B | 9.37B | 14.48B | 11.24B | -9.15B |
| Operating Cash Flow | 16.77B | 15.57B | 15.20B | 15.97B | 15.09B | 14.10B |
| Investing Cash Flow | -9.16B | -8.18B | -5.90B | -1.60B | -3.91B | -23.22B |
| Financing Cash Flow | -8.94B | -8.86B | -12.63B | -12.61B | -10.37B | 11.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥365.84B | 17.54 | 6.80% | 5.16% | -27.00% | 18.03% | |
67 Neutral | ¥333.64B | 23.38 | 5.35% | 4.18% | 2.53% | 1.49% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥256.21B | 11.18 | ― | 4.15% | 1.36% | -1.18% | |
63 Neutral | ¥163.81B | 6.57 | ― | 4.70% | 73.49% | 34.06% | |
58 Neutral | ¥329.02B | 13.66 | ― | 3.56% | 5.45% | 7.40% |